Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 3, 2025 • 10:31 PM ET

Date/Time Source News Release
12/17/2024 07:00 AM EST GlobeNewswire BioCardia Announces Commercial Availability of Morph® DNA(TM) Steerable Introducer Product Family
12/04/2024 08:30 AM EST GlobeNewswire BioCardia Announces Positive Consultation with Japan PMDA on CardiAMP Cell Therapy for Ischemic Heart Failure
11/13/2024 04:05 PM EST GlobeNewswire BioCardia Reports Third Quarter 2024 Business Highlights and Financial Results
11/06/2024 07:00 AM EST GlobeNewswire BioCardia to Host Q3 2024 Corporate Update and Financial Results Conference Call on November 13, 2024
10/28/2024 09:00 AM EDT GlobeNewswire BioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart Failure
09/18/2024 08:30 AM EDT GlobeNewswire BioCardia Regains Full Compliance with Nasdaq Listing Requirements
09/09/2024 04:05 PM EDT GlobeNewswire BioCardia Announces Closing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules
08/30/2024 08:00 AM EDT GlobeNewswire BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules
08/29/2024 08:30 AM EDT GlobeNewswire BioCardia Announces FDA Market Clearance of Morph® DNA(TM) Steerable Introducer Product Family
08/21/2024 07:00 AM EDT GlobeNewswire FDA Approves CardiAMP® Heart Failure II Protocol Amendment to Use Proprietary Cell Population Analysis Screening to Define Treatment
Page

Additional News

As of January 3, 2025 • 10:31 PM ET

Date/Time Source News Release
11/13/2024 07:49 PM EST SeekingAlpha BioCardia, Inc. (BCDA) Q3 2024 Earnings Call Transcript
11/13/2024 04:26 PM EST SeekingAlpha BioCardia GAAP EPS of -$0.61 beats by $0.58
11/13/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Wednesday, November 13th, 2024
11/13/2024 04:36 AM EST US Earnings Reports Expected earnings - BioCardia Inc.
11/12/2024 09:45 AM EST Zacks Femasys Inc. (FEMY) Reports Q3 Loss, Tops Revenue Estimates
11/06/2024 09:15 AM EST Zacks Urogen Pharma (URGN) Reports Q3 Loss, Tops Revenue Estimates
11/04/2024 08:15 AM EST Zacks Precision BioSciences (DTIL) Reports Q3 Loss, Misses Revenue Estimates
10/31/2024 05:15 PM EDT Zacks ChromaDex (CDXC) Beats Q3 Earnings and Revenue Estimates
10/30/2024 05:25 PM EDT Zacks MiMedx (MDXG) Q3 Earnings and Revenues Surpass Estimates
09/18/2024 08:35 AM EDT SeekingAlpha BioCardia regains compliance with Nasdaq Capital Market
Page